Big tech’s spending on healthcare equity deals up 875% in 5 years: What 5 tech giants are up to Life Science
BeiGene Initiates Pivotal Trial of PARP inhibitor Pamiparib (BGB-290) in China in Patients With Ovarian Cancer Life Science